Please ensure Javascript is enabled for purposes of website accessibility

FDA Rejects JJ’s Risperdal for Alzheimer’s-Related Psychosis

New Brunswick’s Johnson & Johnson (NYSE: JNJ) said Thursday its pharmaceutical research and dNew Brunswick”s Johnson & Johnson (NYSE: JNJ) said Thursday its pharmaceutical research and d

NJBIZ STAFF
Write to the Editorial Department at editorial@njbiz.com.

NJBIZ Business Events

NJBIZ Healthcare Heroes 2022

Wednesday, August 10, 2022
NJBIZ Healthcare Heroes 2022

NJBIZ Connect Networking Event

Tuesday, September 13, 2022
NJBIZ Connect Networking Event

NJBIZ Forty Under 40 Awards 2022

Wednesday, September 21, 2022
NJBIZ Forty Under 40 Awards 2022